l 692429 has been researched along with hexarelin in 6 studies
| Studies (l 692429) | Trials (l 692429) | Recent Studies (post-2010) (l 692429) | Studies (hexarelin) | Trials (hexarelin) | Recent Studies (post-2010) (hexarelin) |
|---|---|---|---|---|---|
| 40 | 5 | 1 | 261 | 56 | 39 |
| Protein | Taxonomy | l 692429 (IC50) | hexarelin (IC50) |
|---|---|---|---|
| Platelet glycoprotein 4 | Rattus norvegicus (Norway rat) | 2.08 | |
| Growth hormone secretagogue receptor type 1 | Homo sapiens (human) | 0.017 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (66.67) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Bach, MA; Murphy, MG; Nargund, RP; Patchett, AA; Smith, RG | 1 |
| Bukhari, SNA | 1 |
| Chaung, LY; Dean, DC; Nargund, RP; Patchett, AA; Pong, SS; Smith, RG | 1 |
| Casabiell, X; Casanueva, FF; Dieguez, C; Gualillo, O; Micic, D; Pombo, M | 1 |
| Bach, MA; Fuh, VL | 1 |
| Shimatsu, A | 1 |
5 review(s) available for l 692429 and hexarelin
| Article | Year |
|---|---|
Peptidomimetic growth hormone secretagogues. Design considerations and therapeutic potential.
Topics: Amino Acid Sequence; Animals; Drug Design; Growth Hormone-Releasing Hormone; Hormones; Human Growth Hormone; Humans; Hypothalamo-Hypophyseal System; Molecular Sequence Data; Oligopeptides; Protein Conformation; Receptors, Somatotropin | 1998 |
An insight into the multifunctional role of ghrelin and structure activity relationship studies of ghrelin receptor ligands with clinical trials.
Topics: Animals; Clinical Trials as Topic; Ghrelin; Growth Hormone; Ligands; Peptidomimetics; Receptors, Ghrelin; Structure-Activity Relationship | 2022 |
Growth hormone secretagogues: the clinical future.
Topics: Animals; Benzazepines; Growth Hormone-Releasing Hormone; Human Growth Hormone; Humans; Indoles; Oligopeptides; Spiro Compounds; Tetrazoles | 1999 |
Growth hormone secretagogues: mechanism of action and use in aging.
Topics: Aged; Aging; Animals; Benzazepines; Double-Blind Method; Female; Frail Elderly; Hormone Replacement Therapy; Human Growth Hormone; Humans; Hydrocortisone; Hypothalamo-Hypophyseal System; Indoles; Male; Muscular Atrophy; Oligopeptides; Pituitary Gland, Anterior; Prolactin; Secretory Rate; Somatostatin; Spiro Compounds; Tetrazoles | 1998 |
[Ghrelin-related drugs: clinical perspectives].
Topics: Benzazepines; Clinical Trials, Phase I as Topic; Dipeptides; Drug Design; Dwarfism, Pituitary; Ethylamines; Feeding and Eating Disorders; Ghrelin; Growth Hormone; Humans; Ileus; Indoles; Oligopeptides; Peptide Hormones; Sleep Wake Disorders; Spiro Compounds; Stimulation, Chemical; Tetrazoles | 2004 |
1 trial(s) available for l 692429 and hexarelin
| Article | Year |
|---|---|
Growth hormone secretagogues: mechanism of action and use in aging.
Topics: Aged; Aging; Animals; Benzazepines; Double-Blind Method; Female; Frail Elderly; Hormone Replacement Therapy; Human Growth Hormone; Humans; Hydrocortisone; Hypothalamo-Hypophyseal System; Indoles; Male; Muscular Atrophy; Oligopeptides; Pituitary Gland, Anterior; Prolactin; Secretory Rate; Somatostatin; Spiro Compounds; Tetrazoles | 1998 |
1 other study(ies) available for l 692429 and hexarelin
| Article | Year |
|---|---|
Identification of a new G-protein-linked receptor for growth hormone secretagogues.
Topics: Animals; Benzazepines; Binding, Competitive; Growth Hormone; GTP-Binding Proteins; Guanosine 5'-O-(3-Thiotriphosphate); Indoles; Magnesium; Male; Oligopeptides; Pituitary Gland, Anterior; Rats; Rats, Wistar; Receptors, Cell Surface; Receptors, Somatotropin; Spiro Compounds; Swine; Tetrazoles | 1996 |